5th International Congress of Corneal Cross Linking

Communicating and understanding the technology of Cross Linking

Program on 5th of December 2009

08:00
Welcome to Leipzig from the Head of Department of Ophthalmology
P. Wiedemann
08:10
Introduction Congress Organisator
H.P. Iseli
Block I

Basic science

Chair: M. Mrochen/E. Spoerl

08:15
Biomechanical condition of the cornea as a new indicator for pathological and structural changes
E. Spoerl
08:40
Proliferation of human limbal epitheial cells after CXL in vitro
A. Thorsrud
08:50
Limbus area and IOP measurrement in Rabbit eyes after CXL
V. Kozobolis
09:00
Challenges in establishing a rabbit model of CXL
J.M. Stewart
09:10
Diffusion measurement of Riboflavin in the cornea
M. Mrochen
09:20
Evaluation of stromal riboflavin uptake and homogeneity
A. Soendergaard
09:30
UV light source Intra-beam profiling
J. McAlister
09:40
Initial studies using aliphatic beta-nitro alcohols for therapeutic corneal cross-linking
D.C. Paik

9:50 Coffee break

Corneal Changes with Cross Linking

Chair: El Hage/H.P. Iseli

10:20
In vivo confocal microscopy, an inner vision of the cornea - a major review
A. Zhivov
10:35
Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking
P. Vinciguerra
10:45
CXL effects in keratoconus evaluated by anterior segment OCT
A. Tytiun
10:55
Effect of CXL on corneal topography, visual acuity and contrast sensitivity
R. Lamy
Block II

Different Techniques

Chair: Vinciguerra/Raiskup

11:05
CXL using a corneal pocket
A. Daxer
11:15
Pharmacological modification of the epithelial permeability by Benzalkonium Chloride in CXL
A. Kissner
11:25
Pilot study of T-Cat and CXL for Keratoconusé: 6-month results
M. Attenborough
11:35
Controlling advanced keratoconic aberropia
S. Kandelman
11:45
CXL in thin corneas
F. Raiskup

11:55 Lunch

Block III

Clinical Results

Chair: Hafezi/Joshi

13:20
Cross – linking in various categories in African eyes / 284 eyes
M. Joshi
13:30
Corneal Cross-linking for the treatment of keratoconus: preliminary Results
V. Jovanovic
13:40
Australian Follow Up
C. Wittig
13:50
CXL for corneal ectasia: An Asian perspective
L. Lim
14:00
Our results in Therapy of Keratokonus by CXL
R. Mahmoud
14:10
Surgical visual rehabilitation after CXL in Keratoconus patients: one year results
J. Vryghem
14:20
CXL in pediatric patients with documented advanced keratoconus
E. Albé
14:30
CXL for ectasia after excimer laser refractive surgery: One year results
P. Vinciguerra
14:40
CXL in Keratoconus treatment - 2 years of Warsaw experience
J. Izdebska

Different Aspects

Chair: Vryghem/Koller

14:50
Scleral Cross Linking
H.P. Iseli
15:00
Severe Keratitis after CXL for keratokonus
G. Paganoni
15:10
Can we repeat CXL?
M. Lombardi
15:20
Tonometry in keratoconic eyes before and after CXL using three differnt tonometers
V. Kozobolis
15:30
Corneal thickness measurement using Visante, ultrasound and pentacam pachymetry after CXLfor keratoconus
I. Paladini

15:40 Coffee Break

Block IV

Other Applications

Chair: T. Seiler, C. Wittig

16:10
CXL for Keratoconus in Down syndrome
C. Koppen
16:20
Keraflex KXL: initial results using the vedera KXS with patterned CXL (KXL) for myopia reduction
P. Hersh
16:30
Special cases
T. Seiler
16:40
Preliminaty results from Clinical pilot study on CXL as keratitis therapy
J. Mortensen
16:50
CXL for treatment of infectious keratitis with impending perforation
A. Schrier
17:00
Effect of CXL on corneal thickness in patients with corneal edema
S. Kandelman
17:10
Modified CXL reduces corneal edema and diurnal visual fluctuations in Fuch's dystrophy
F. Hafezi
17:20
Final remarks and end of Congress
H.P. Iseli